跳至主要内容
临床试验/DRKS00014718
DRKS00014718已完成未知

utri-kinetics of 7 selected peptides from rice

BASF SE0 个研究点目标入组 10 人开始时间: 2018年5月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
BASF SE
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Participants in this study are 10 healthy men and women between 18 and 50 years with a body mass index (BMI) between 19 and 30 kg/m², good physical and mental condition, evidenced by inconspicuous medical history: such as ECG, vital signs, results of biochemistry & hematology.

排除标准

  • Smoker, vegan, vegetarian, or subjects with a coffee consumption >3 cups/day.
  • Relevant history or presence of any severe medical disorder, potentially interfering with this study (e.g. mal absorption, chronic gastro-intestinal diseases, heavy depression, diabetes, acute cancers within last 3 years except basal cell carcinoma of the skin, etc.).
  • A significant CVD event within last 3 mo. incl. myocardial infarction, stroke, congestive heart failure. Significant changes in lifestyle or medication (within last 3 mo.) or surgical intervention or surgical procedure such as bariatric surgery. Application of corticoids (intravenously, orally or intraarticularly) and other immune-suppressing drug (within last 3 mo.). For this study clinically relevant abnormal laboratory, ECG, vital signs or physical findings at screening. Blood donation within 1 month prior to study start or during study . Extreme dietary regimes”: vegan lifestyle, weight loss diet with <1200 kcal/day for women and <1800 kcal for men. Regular intake of drugs or supplements possibly interfering with this study (e.g. omega-3, curcumin, protein shakes or bars etc.) within 2 weeks prior to study start or during study. Subjects with history of drug, alcohol or other substance abuse, or other factors limiting their ability to co-operate during the study. Known HIV-infection. Known acute or chronic hepatitis B and C infection. Known pregnancy, breast feeding or intention to become pregnant during the study. Participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study, anticipating any planned changes in lifestyle for the duration of the study. Subjects considered inappropriate for the study by investigators, including subjects who are unable or unwilling to show compliance with the protocol, subjects not willing to sign the study consent.

研究者

发起方
BASF SE

相似试验